Premium
Pan‐Trk immunoexpression in a superficial malignant ossifying fibromyxoid tumor with ZC3H7B‐BCOR fusion: A potential obfuscating factor in the era of targeted therapy
Author(s) -
Linos Konstantinos,
Kerr Darcy A.,
Sumegi Janos,
Bridge Julia A.
Publication year - 2021
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/cup.13915
Subject(s) - trk receptor , pathology , medicine , immunohistochemistry , targeted therapy , cancer research , cancer , nerve growth factor , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom